Maysaa M. Saleh
In Vitro Anticancer Properties of Novel Bis-Triazoles
Saleh, Maysaa M.; Abuarqoub, Duaa A.; Hammad, Alaa M.; Hossan, Md Shahadat; Ahmed, Najneen; Aslam, Nazneen; Naser, Abdallah Y.; Moody, Christopher J.; Laughton, Charles A.; Bradshaw, Tracey D.
Authors
Duaa A. Abuarqoub
Alaa M. Hammad
Md Shahadat Hossan
Najneen Ahmed
Nazneen Aslam
Abdallah Y. Naser
Christopher J. Moody
Professor CHARLES LAUGHTON CHARLES.LAUGHTON@NOTTINGHAM.AC.UK
PROFESSOR OF COMPUTATIONAL PHARMACEUTICAL SCIENCE
Dr TRACEY BRADSHAW tracey.bradshaw@nottingham.ac.uk
ASSOCIATE PROFESSOR
Contributors
Asita Elengoe
Editor
Abstract
Here, we describe the anticancer activity of our novel bis-triazoles MS47 and MS49, developed previously as G-quadruplex stabilizers, focusing specifically upon the human melanoma MDA-MB-435 cell line. At the National Cancer Institute (NCI), USA, bis-triazole MS47 (NCS 778438) was evaluated against a panel of sixty human cancer cell lines, and showed selective, distinct multi-log differential patterns of activity, with GI50 and LC50 values in the sub-micromolar range against human cancer cells. MS47 showed highly selective cytotoxicity towards human melanoma, ovarian, CNS and colon cancer cell lines; in contrast, the leukemia cell lines interestingly showed resistance to MS47 cytotoxic activity. Further studies revealed the potent cell growth inhibiting properties of MS47 and MS49 against the human melanoma MDA-MB-435 cell line, as verified by MTT assays; both ligands were more potent against cancer cells than MRC-5 fetal lung fibroblasts (SI > 9). Melanoma colony formation was significantly suppressed by MS47 and MS49, and time- and dose-dependent apoptosis induction was also observed. Furthermore, MS47 significantly arrested melanoma cells at the G0/G1 cell cycle phase. While the expression levels of Hsp90 protein in melanoma cells were significantly decreased by MS49, corroborating its binding to the G4-DNA promoter of the Hsp90 gene. Both ligands failed to induce senescence in the human melanoma cells after 72 h of treatment, corroborating their weak stabilization of the telomeric G4-DNA.
Citation
Saleh, M. M., Abuarqoub, D. A., Hammad, A. M., Hossan, M. S., Ahmed, N., Aslam, N., Naser, A. Y., Moody, C. J., Laughton, C. A., & Bradshaw, T. D. (2023). In Vitro Anticancer Properties of Novel Bis-Triazoles. Current Issues in Molecular Biology, 45(1), 175-196. https://doi.org/10.3390/cimb45010014
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 8, 2022 |
Online Publication Date | Dec 29, 2022 |
Publication Date | 2023-01 |
Deposit Date | Jan 3, 2023 |
Publicly Available Date | Jan 9, 2023 |
Journal | Current Issues in Molecular Biology |
Print ISSN | 1467-3037 |
Electronic ISSN | 1467-3045 |
Publisher | Horizon Scientific Press |
Peer Reviewed | Peer Reviewed |
Volume | 45 |
Issue | 1 |
Pages | 175-196 |
DOI | https://doi.org/10.3390/cimb45010014 |
Keywords | Article, apoptosis assay, bis-triazoles, cell cycle analysis, G4-DNA, Hsp90, melanoma, NCI 60 cell line panel, senescence |
Public URL | https://nottingham-repository.worktribe.com/output/15436709 |
Files
cimb-45-00014
(14.9 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Optimizing Excipient Properties to Prevent Aggregation in Biopharmaceutical Formulations
(2023)
Journal Article
Linear Binary Classifier to Predict Bacterial Biofilm Formation on Polyacrylates
(2023)
Journal Article
GLIMPS: A Machine Learning Approach to Resolution Transformation for Multiscale Modeling
(2021)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search